Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-15

Clinical Trial Update: Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation [NA]

View source ↗

Summary

A completed clinical trial evaluating whether oral antioxidant supplementation affects drusen morphology in nonexudative age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral antioxidant supplements (antioxidants)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: Macular Degeneration | NA | Status: COMPLETED